Coronavirus therapeutics. Volume II, Clinical management and public health / edited by Alexzander A.A. Asea, Punit Kaur.
Asea, Alexzander A. A., editor; Kaur, Punit, editor
2021
RC772.V5 C67 2021
Available Online

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
Coronavirus therapeutics. Volume II, Clinical management and public health / edited by Alexzander A.A. Asea, Punit Kaur.
ISBN
3030851133 (electronic book)
9783030851132 (electronic bk.)
3030851125
9783030851125
DOI
https://doi.org/10.1007/978-3-030-85113-2
Published
Cham, Switzerland : Springer, [2021]
Language
English
Description
1 online resource
Item Number
10.1007/978-3-030-85113-2 doi
Call Number
RC772.V5 C67 2021
Dewey Decimal Classification
616.2/414
616.9/1
Summary
The book Coronavirus Therapeutics Volume II provides the most comprehensive review on contemporary knowledge on the consequences during the outbreak of Coronavirus. This also describes the clinical features, diagnostic evaluation and management of Coronavirus patients. Using an integrative approach to the understanding of paradigm gap in host-pathogen interaction studies to the management of Coronavirus patients in the Intensive Care Unit to the current challenges for the effective management of Coronavirus pandemic risk factors including diabetes, hypertension, obesity and repercussion on the central and peripheral nervous system. Key basic and clinical research laboratories from major universities, academic medical hospitals, biotechnology and pharmaceutical laboratories around the world have contributed articles that review present research activity on the role of heat shock proteins in human diseases and importantly project the field into the future. The book is a must read for graduate students. medical students, basic science researchers and postdoctoral scholars in the fields of Cancer Biology, Oncology, Cardiovascular Diseases, Microbiology, Inflammation, Translational Medicine, Clinical Research, Biotechnology, Cell & Molecular Medicine, Pharmaceutical Scientists and Researchers involved in Drug Discovery.
Access Note
Access limited to authorized users.
Source of Description
Online resource; title from digital title page (viewed on March 28, 2022).
Added Author
Asea, Alexzander A. A., editor
Kaur, Punit, editor
Series
Advances in experimental medicine and biology ; v. 1353.
Available in Other Form
Coronavirus therapeutics. Volume II, Clinical management and public health.
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
Clinical features, diagnostic evaluation and management of COVID-19 patients
Outbreak of COVID-19: A Detailed Overview and Its Consequences
A paradigm gap in host-pathogen interaction studies: Lesson from the COVID-19 pandemic
SARS/CoV-2: Behavioral Host Manipulation
Management of COVID-19 in the Intensive Care Unit
First wave of Covid-19 pandemic in Italy: data and evidence
Risk factors for COVID-19: diabetes, hypertension and obesity
Current challenges for the effective management of the COVID-19 pandemic
COVID-19 Outbreak Challenges in Indian Migrant Pregnant and Lactating Mothers: Learnt Lesson Demands Phronesis and Hierarchical Strategies for Such Future Pandemics
COVID-19 and Extracorporeal Membrane Oxygenation
COVID-19's Clinical-Pathological Evidence in Relation to its Repercussion on the Central and Peripheral Nervous System
Anatomopathological Aspects and Clinical Correlation of COVID-19: A Systematic Review
SARS-CoV-2 liability: the hidden mystery behind its presentation in children.

Browse Subjects

Show more subjects...

Statistics

from
to
Export